How DarioHealth turned the smartphone into a user-friendly glucose monitor

When DarioHealth (NSDQ:DRIO) CEO Erez Raphael looks at the medical device world, he sees solutions that were designed by healthcare professionals and doctors – and this presents a stark contrast with the consumer device industry, he pointed out. “We have seen there are a lot of cases, most of the cases in the industry, where the […]

Imagining the future of heart pump technology

Dr. John O’Connell, VP, Medical Affairs & Medical Director, Mechanical Circulatory Support, Abbott Since its introduction more than 50 years ago, the left ventricular assist device has evolved from being a temporary solution to a long-term option for patients recovering from heart failure. Now, companies are engineering the LVAD of the future to be smaller

The 11 most innovative medical devices of 2017

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Abbott’s $5B acquisition of Alere set to close tomorrow

Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary. The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro […]

Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem

Bigfoot Biomedical‘s chief executive is excited about Abbott‘s (NYSE:ABT) latest regulatory win – and it’s not just because the two companies have an established partnership. Yesterday, the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring system. It’s the first device of its kind, allowing patients to track their blood glucose levels without the use […]

How Abbott is making good on investor promises

Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ

The 20 Largest Medical Device Companies In the World

When it comes to the largest medical device companies, it’s a changing cast of players – as demonstrated once again in Medical Design & Outsourcing’s latest Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Insulet touts real-world data for Omnipod insulin management tech

Insulet (NSDQ:PODD) touted real-world data today for its Omnipod insulin management system at the Congress of the European Association for the Study of Diabetes. The data come from a study of nearly 39,000 patients with Type I and Type II diabetes who received insulin through the Omnipod system and had at least three months of data […]

Abbott’s new contact ablation catheter: Here’s what you need to know

The new TactiCath contact ablation catheter unites EndoSense and St. Jude Medical technologies that Abbott acquired, marrying fiber optics, flexibility and 3D mapping. If you want your grilled cheese to cook faster, you press it into the pan with your spatula. That’s contact force, the principle behind Abbott’s TactiCath contact force ablation catheter, according to

Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment

Just one week after Abbott (NYSE:ABT) said it inked a deal with Bigfoot Biomedical to develop an automated diabetes management system, CEO Miles White told analysts that he thinks Bigfoot is playing an important role in the strategic change taking place in the space. “It’s a fairly clever service and approach that I think will create, not just an

Abbott heart device shown safe for infants

Developing very small devices that can be used for children is a significant challenge in the market. FDA is cautious to approve new devices into this market for vulnerable patients. But the efforts are needed to improve the health of babies, particularly those born with heart defects. Abbott’s reduced sized Amplatzer duct occluder II (ADO

Abbott’s MitraClip can be implanted through the jugular vein, too

A Canadian cardiologist has successfully inserted Abbott Labs’s MitraClip through the jugular vein instead of the femoral vein, according to a recent report. Dr. Neil Fam inserted the Abbott Laboratories device into an 86-year old patient with severe mitral regurgitation. Because of the patient’s age, traditional surgery to repair her mitral valve was not an

Abbott lands French reimbursement win for FreeStyle Libre glucose monitor

Abbott (NYSE:ABT) said today it won national reimbursement from the French Health ministry for its FreeStyle Libre wearable glucose monitor. The FreeStyle Libre is designed to monitor glucose through a sensor worn on the back of the upper arm for 2 weeks, without the need for the finger prick calibration required by continuous glucose monitoring

Superbugs: Diagnostic test makers think they have an answer

Becton Dickinson and other diagnostic test makers have launched a global push to promote more testing, in the hopes of identifying antibiotic-resistant superbugs before they become a serious problem. AdvaMedDx, a group that represents diagnostic test manufacturers, announced the initiative on Friday in collaboration with the Joint United Nations Program on HIV/AIDs at the World Economic Forum

FDA: St. Jude Medical devices really do have a cybersecurity problem

FDA issued a safety communication on January 9, 2017, detailing St. Jude Medical products that could be vulnerable to cyber threats. These threats could result in rapid battery depletion or administration of inappropriate pacing or shocks—potentially lethal outcomes. FDA noted that there have been no reports of patient harm related to the cybersecurity risks. The news comes